Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Actavis Must Keep its Older Alzheimer’s Pill on the Market
Actavis Must Keep its Older Alzheimer’s Pill on the Market
Actavis Must Keep its Older Alzheimer’s Pill on the Market
Submitted by
admin
on May 22, 2015 - 6:23pm
Source:
WSJ Pharmalot
News Tags:
Actavis
Alzheimer's disease
hard switch
Namenda XR
Headline:
Actavis Must Keep its Older Alzheimer’s Pill on the Market
Do Not Allow Advertisers to Use My Personal information
